The identification of driver mutations has numerous clinical applications:
- Targeted Therapy: Drugs can be designed to specifically target proteins produced by driver mutations, improving treatment efficacy and reducing side effects.
- Diagnostic Biomarkers: Certain driver mutations can serve as biomarkers for early detection of cancer.
- Prognostic Indicators: The presence of specific driver mutations can provide information about the likely course and outcome of the disease.
- Personalized Medicine: Treatment plans can be tailored based on the specific driver mutations present in a patient's cancer.
